PL2949670T3
Antibodies binding preferentially human csf1r extracellular domain 4 and their use
Abstract
This record has no abstract on file.
Term
4.2 yearsto projected expiry
Projected expiry 7 December 2030, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
13 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13
84 members in 36 offices
Priority claims17
| Document | Office | Kind | Date |
|---|---|---|---|
| 09015310 | European Patent Office (EPO) | A | |
| 09015310 | European Patent Office (EPO) | A | |
| 10173407 | European Patent Office (EPO) | A | |
| 10173407 | European Patent Office (EPO) | A | |
| 10794936 | European Patent Office (EPO) | A | |
| 10794936 | European Patent Office (EPO) | A | |
| 15168902 | European Patent Office (EPO) | A | |
| 2010069090 | European Patent Office (EPO) | W | |
| 2010069090 | European Patent Office (EPO) | W | |
| 09015310 | – | – | – |
| 10173407 | – | – | – |
| 151689023 | – | – | – |
| EP20090015310 | – | – | – |
| EP20100173407 | – | – | – |
| EP20100794936 | – | – | – |
| EP20150168902 | – | – | – |
| WO2010EP69090 | – | – | – |
Members84
| Document | Office | Kind | |
|---|---|---|---|
| CA2780692A1 | Canada | A1 | |
| WO2011070024A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2011165156A1 | United States of America | A1 | |
| TW201129381A | Taiwan Province of China | A | |
| AR079333A1 | Argentina | A1 | |
| AU2010329934A1 | Australia | A1 | |
| CR20120215A | Costa Rica | A | |
| IL219595A0 | Israel | A0 | |
| SG181589A1 | Singapore | A1 | |
| ECSP12011964A | Ecuador | A | |
| MX2012006553A | Mexico | A | |
| KR20120098872A | Republic of Korea | A | |
| CL2012001547A1 | Chile | A1 | |
| CO6541621A2 | Colombia | A2 | |
| EP2510010A1 | European Patent Office (EPO) | A1 | |
| PE20121398A1 | Peru | A1 | |
| CN102791738A | China | A | |
| JP2013513367A | Japan | A | |
| HK1176361A | Hong Kong, China | A | |
| HK1176361A1 | Hong Kong, China | A1 | |
| NZ599516A | New Zealand | A | |
| MA34780B1 | Morocco | B1 | |
| TWI422388B | Taiwan Province of China | B | |
| RU2012128651A | Russian Federation | A | |
| KR101434070B1 | Republic of Korea | B1 | |
| JP5677451B2 | Japan | B2 | |
| US8999327B2 | United States of America | B2 | |
| AU2010329934B2 | Australia | B2 | |
| US2015158950A1 | United States of America | A1 | |
| JP2015120697A | Japan | A | |
| AU2015213308A1 | Australia | A1 | |
| US2015274830A1 | United States of America | A1 | |
| US2015274831A1 | United States of America | A1 | |
| CN102791738B | China | B | |
| RU2565541C2 | Russian Federation | C2 | |
| EP2510010B1 | European Patent Office (EPO) | B1 | |
| EP2949670A1 | European Patent Office (EPO) | A1 | |
| DK2510010T3 | Denmark | T3 | |
| CN105218672A | China | A | |
| PT2510010E | Portugal | E | |
| ES2557454T3 | Spain | T3 | |
| SI2510010T1 | Slovenia | T1 | |
| HRP20160131T1 | Croatia | T1 | |
| UA111322C2 | Ukraine | C2 | |
| HUE026201T2 | Hungary | T2 | |
| PL2510010T3 | Poland | T3 | |
| RS54596B1 | Serbia | B1 | |
| US9499624B2 | United States of America | B2 | |
| US9499625B2 | United States of America | B2 | |
| US9499626B2 | United States of America | B2 | |
| BR112012013717A2 | Brazil | A2 | |
| MY159679A | Malaysia | A | |
| ZA201203782B | South Africa | B | |
| US2017029517A1 | United States of America | A1 | |
| IL219595A | Israel | A | |
| HK1219739A | Hong Kong, China | A | |
| HK1219739A1 | Hong Kong, China | A1 | |
| CY1117331T1 | Cyprus | T1 | |
| US9663580B2 | United States of America | B2 | |
| JP2017123850A | Japan | A | |
| AU2015213308B2 | Australia | B2 | |
| US2017320953A1 | United States of America | A1 | |
| BR112012013717A8 | Brazil | A8 | |
| MX353706B | Mexico | B | |
| US9879085B2 | United States of America | B2 | |
| US2018208662A1 | United States of America | A1 | |
| US2018244788A1 | United States of America | A1 | |
| CA2780692C | Canada | C | |
| US10072087B2 | United States of America | B2 | |
| US10077314B1 | United States of America | B1 | |
| EP2949670B1 | European Patent Office (EPO) | B1 | |
| US2019071507A1 | United States of America | A1 | |
| DK2949670T3 | Denmark | T3 | |
| US10287358B2 | United States of America | B2 | |
| PT2949670T | Portugal | T | |
| LT2949670T | Lithuania | T | |
| SI2949670T1 | Slovenia | T1 | |
| HRP20190762T1 | Croatia | T1 | |
| RS58693B1 | Serbia | B1 | |
| PL2949670T3This record | Poland | T3 | |
| ES2722300T3 | Spain | T3 | |
| US2019300614A1 | United States of America | A1 | |
| HUE044179T2 | Hungary | T2 | |
| BR112012013717B1 | Brazil | B1 |
Numbers
- Publication
- 2949670
- Publication, DOCDB
- 2949670
- Publication, EPODOC
- PL2949670T
- Application
- 15168902
- Application, DOCDB
- 15168902
- Application, EPODOC
- PL20150168902T
Titles2
- English
- ANTIBODIES BINDING PREFERENTIALLY HUMAN CSF1R EXTRACELLULAR DOMAIN 4 AND THEIR USE
- Polish
- Przeciwciała wiążące się preferencyjnie z zewnątrzkomórkową domeną 4 ludzkiego CSF-1R i ich zastosowanie
Classification
- CPC, 20
- C07K16/2866
- C07K16/28
- C07K2317/56
- C07K2317/565
- C07K2317/567
- C07K2317/73
- C07K2317/76
- A61K2039/505
- C07K2317/92
- C07K2317/24
- A61P19/08
- A61P19/10
- A61P29/00
- A61P35/00
- A61P35/04
- A61P37/00
- A61K39/395
- C07K2317/21
- C07K2317/31
- C07K2317/622
- IPC, 4
- C07K16 28
- A61K39 00
- A61P35 00
- A61P37 00